Greg Paoli earned both his Bachelor's and Master's degrees from the University of Waterloo, specializing in engineering and systems design. His early career involved diverse research projects at the University of Waterloo's Institute for Risk Research. Greg later founded Decisionalysis Risk Consultants in 1997 and co-founded Risk Sciences International in 2006. He has served on multiple high-profile committees, including those under the U.S. National Academy of Sciences. As CEO of Risk Sciences International, Greg focuses on risk-based regulatory transformations and has developed enabling technologies like FDA-iRISK. His work spans various sectors, from food and chemical safety to public health, and he continues to contribute to the advancement of risk-based decision-making methodologies.

Jennifer Go holds a BHSc in Health Sciences and an M.Sc. in Epidemiology, both from the University of Ottawa. Her academic work has spanned epigenetics, mental illness, and environmental exposures. Joining Risk Sciences International in 2017 as a Risk Analyst, she specializes in epidemiology. Jennifer's skill set includes systematic reviews, data manipulation, and statistical modeling. She has worked on diverse projects, ranging from pharmacoeconomic evaluations to analyses involving large datasets and electronic health records.

As a Microbiologist with Risk Sciences International, Dr. Sattar contributes his deep expertise in pathogen ecology, environmental microbiology, and infection control technologies to support RSI’s work in health risk assessment and risk mitigation. His insights guide RSI’s contributions to evidence-based disinfection strategies, microbial exposure modelling, and policy-relevant evaluations of infectious disease risk across water, air, food, and surface-contact pathways.

Since joining Risk Sciences International in 2019, Martin has served in Business Development, leading RSI’s business expansion efforts across Canadian and global markets. He is instrumental in identifying and qualifying opportunities, coordinating multidisciplinary proposal teams, developing project frameworks, and supporting contract negotiations. His expertise spans the entire procurement spectrum, including competitive tenders, standing offers, supply arrangements, and unsolicited proposals.

Cemil ‘Jim’ Alyanak joined Risk Sciences International (RSI) in 2018 and serves as Vice-President, Communications and Strategic Initiatives. In this senior leadership role, he leads RSI’s risk communications practice, drives cross-cutting initiatives, advances strategic in-house projects, and expands the company’s international presence and partnerships. As creator of CRAFT (the Collective Risk Action Framework and Toolkit) and the Global Risk Census, Alyanak has helped establish RSI as a global innovator in stakeholder- and constituency-centered risk engagement. His expertise in perception analysis and communications strategy enables RSI to address complex challenges across public health, regulatory affairs, environmental risk, and humanitarian crisis response. From pandemic-era messaging to multistakeholder workshops and regulator support, his work consistently focuses on aligning message, audience, and outcomes that can be measured. Recognized for his ability to navigate cross-cultural contexts and indigenous knowledge systems, Alyanak has worked extensively on in-region projects with local and indigenous communities worldwide. This grassroots experience informs his current portfolio, which includes collaboration and consensus-building projects that unite stakeholders and constituencies in addressing both shared and similar risks. He also provides regional, federal, and international policy guidance to companies and governing bodies seeking to design risk-informed policies, instruments, and frameworks. Drawing on extensive emergency preparedness and disaster response experience, Alyanak now leads RSI’s Disaster and Emergency-related projects, advancing practical, risk-based solutions to complex emergencies and strengthening resilience across sectors.

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments related to environmental contaminants and consumer products. His practice group supports government agencies, regulatory bodies, and international partners in making science-informed decisions that safeguard public health.

Dr. Cote is an Associate Expert at Risk Sciences International, where she brings world-class expertise in environmental health risk assessment, risk management, and science-informed public policy. She contributes to projects that require strategic application of risk methodologies to environmental, occupational, and chemical exposure issues—often at the intersection of regulation, sustainability, and health protection. Her work with RSI benefits from her deep understanding of both U.S. and international regulatory environments and her commitment to advancing decision-making through transparent and defensible science.

Dr. Al-Zoughool has maintained a long-standing relationship with Risk Sciences International, both as a scientific collaborator and as a co-investigator on complex international projects. His work with RSI focuses on high-level public health risk modeling, mechanistic data analysis, and toxicological risk assessment of major environmental contaminants in air, soil, and water, including formaldehyde, lead, and 1,4-dioxane. His research also extends to methodological innovation and the development of evidence-based strategies for environmental and occupational health policy.

As an Associate Expert with Risk Sciences International, Dr. Arnold brings clinical depth and field experience to RSI’s work in occupational health risk assessment and workplace safety policy development. He provides expert insight on topics such as exposure-related health outcomes, physical and psychological stressors in industrial settings, and the integration of clinical data into population-level risk models.

As a Senior Advisor and Associate Expert with Risk Sciences International, Dr. Leiss contributes unparalleled insight into the design, delivery, and evaluation of risk communication strategies for government, regulatory bodies, and civil society. His legacy work in building public trust around controversial science and his decades of thought leadership on consensus-building, science-based policy, and societal responses to risk make him a foundational contributor to RSI’s mission.